Immunovaccine

Immunovaccine was the former name of Canadian biotechnology company IMV Inc., which developed immunotherapy technologies. The company changed its name to IMV in May 2018. The legacy Canadian entities entered bankruptcy in December 2023 after court-supervised restructuring and an asset sale.